Fulvenat 250® Fulvestrant Injection

Fulvenat 250 mg contains fulvestrant and is used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in eligible women. It works by blocking and breaking down oestrogen receptors on cancer cells, helping slow the growth of hormone-sensitive tumours.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.